CFL1 and chronic myelogenous leukemia, BCR-ABL1 positive: When CML was diagnosed, the median expression level of cofilin was 1.92 (0.77-3.05), and it increased significantly after 3 months of imatinib treatment [2.94 (1.58-4.57), p<0.001] (Figure 1B).